HCA Healthcare, Inc. vs Abbvie Inc.
HCA vs ABBV — side-by-side comparison from reported financials. HCA leads 6, ABBV leads 4 of 10 comparable metrics.
HCA Healthcare, Inc.
HCA · Healthcare
$445.04+0.01%Strained
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | HCA | ABBV |
|---|---|---|
| Price | $445.04 | $276.43 |
| Market cap | $96.3B | $488B |
| Revenue (TTM) | $78.0B | $64.4B |
| Revenue growth | +7.9% | +1.8% |
| Net margin | 8.8% | 9.8% |
| Free cash flow | $6.00B | $18.2B |
| Net cash (debt) | ($45.5B) | ($56.2B) |
| 1-year price return | +6.2% | +19.8% |
| P/E | 14.3 | 77.4 |
| P/E vs own history (cheap-side %) | 44% | 23% |
| Dividend yield | 0.70% | 2.45% |
| Return on equity | 696% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 9 of 11 | 9 of 11 |
| Employees | 320,000 | 57,000 |
Full résumé-style profiles: HCA CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.